CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk

ورودی‌های بالینی بیمار

حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
cha2ds2 vasc score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Very Low Risk0–0
  • Low Risk1–1
  • Moderate Risk2–2
  • Moderate-High Risk3–3

Clinical Decision Pathway

Clinical Decision Pathway & Next Steps

Stroke, TIA & Intracranial Hemorrhage — سکته مغزی، TIA و خونریزی داخل جمجمه

Clinical Rationale:

Risk-stratify TIA with ABCD2, quantify stroke severity with NIHSS, evaluate early CT changes with ASPECTS, measure hematoma volume with ABC/2 and mortality with ICH Score, then balance anticoagulation with CHA2DS2-VASc and HAS-BLED.

← Previous Step in PathwayPrior step

Intracerebral Hemorrhage (ICH) Score

امتیاز ICH (خونریزی داخل مغزی)

Review previous tool

Recommended Clinical Next Steps:

  • HAS-BLED Score for Major Bleeding Risk

    امتیاز HAS-BLED (ریسک خونریزی عمده)

    Why next: Major bleeding risk with anticoagulation
Direct Clinical Answer

The CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk calculator is designed for bedside calculating the risk of stroke in patients with non-valvular atrial fibrillation, aiding in the decision regarding oral anticoagulation in clinical practice. The resulting score directly guides clinician decision-making regarding initiating guideline-directed medical.

Clinical Guidelines & Evidence

Calculates the risk of stroke in patients with non-valvular atrial fibrillation, aiding in the decision regarding oral anticoagulation

Clinical Indication

The CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk is indicated for bedside clinical practice to support Calculates the risk of stroke in patients with non-valvular atrial fibrillation, aiding in the decision regarding oral anticoagulation. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.

Limitations & Contraindications

In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.

Clinical Pearls & Action Plan

Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines.

Formula & Variables:

CHA₂DS₂-VASc = C + H + A₂ + D + S₂ + V + A + Sc

Input Parameters

NameTypeRequiredDescription
ageintegerYesPatient's age in years(years)
sexstringYesPatient's biological sex
congestive_heart_failurebooleanYesHistory of congestive heart failure or left ventricular dysfunction (LVEF ≤40%)
hypertensionbooleanYesHistory of arterial hypertension
stroke_tia_thromboembolismbooleanYesPrevious history of stroke, TIA (transient ischemic attack) or thromboembolism
vascular_diseasebooleanYesVascular disease (previous myocardial infarction, peripheral artery disease or aortic plaque)
diabetesbooleanYesHistory of diabetes mellitus

Score Interpretation & Guidance

RangeStageDescription
0–0Very Low RiskAnnual stroke risk: 0.3%
1–1Low RiskAnnual stroke risk: 0.9%
2–2Moderate RiskAnnual stroke risk: 2.9%
3–3Moderate-High RiskAnnual stroke risk: 4.6%
4–4High RiskAnnual stroke risk: 6.7%
5–5High RiskAnnual stroke risk: 10.0%
6–6Very High RiskAnnual stroke risk: 13.6%
7–9Extreme RiskAnnual stroke risk: >15%

Evidence-Based References (EBM)

  • Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263-72.
  • January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Circulation. 2019;140(2):e125-e151.
  • Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. Eur Heart J. 2021;42(5):373-498.

Related calculators